REGISTER BY AUGUST 11, 2017 FOR EARLY BIRD RATES
This annual conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer's disease and related dementias. The ADDF's funded investigators and leading scientists in the field present their current research progress and stimulate discussion. The conference offers ample opportunity for collaboration and partnering.
The 2017 program is organized into four sessions.
Session 1: Neuroinflammation
Jurgen Claassen, PhD, Radboud University
Alpaslan Dedeoglu, MD, PhD, Boston University School of Medicine
Milton Greenberg, PhD, Vivreon Biosciences
Philip Haydon, PhD, GliaCure
D. Martin Watterson, PhD, Northwestern University
Session 2: Neuroprotection and Neural Regeneration
Roberta Diaz Brinton, PhD, University of Arizona Health Sciences
Travis Dunckley, PhD, Translational Genomics Research Institute
Leen Kawas, PhD, M3 Biotechnology
Michael Peel, PhD, Cypralis, Ltd.
William J. Ray, PhD, MD Anderson Cancer Center
Yan Jessie Zhang, PhD, University of Texas, Austin
Session 3: Epigenetics and Cognitive Enhancing
Lenore Launer, PhD, National Institute on Aging
Allan Levey, MD, PhD, Emory University
Tamara Maes, PhD, Oryzon Genomics
Ana Pereira, MD, The Rockefeller University
Maria Quinton, PhD, Rodin Therapeutics
Neil Vasdev, PhD, Massachusetts General Hospital
Session 4: Misfolded Proteins and Proteostasis
Steven Finkbeiner, MD, PhD, Gladstone Institute of Neurological Disease, UCSF
Brent Stockwell, PhD, Columbia University
Dominic Walsh, PhD, Brigham & Women's Hospital
Xinglong Wang, PhD, Case Western Reserve University School of Medicine
If you are a graduate student or postdoctoral fellow, you can apply for a Young Investigator Scholarship by July 14, 2017 to attend the conference for free.